MedDataX Logo

Retrospective Analysis of Clinical Features in Ventriculoperitoneal Shunt Infectionsin Adults

NCT ID: NCT00524108

Last Updated: 2012-08-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-08-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are:

* To describe the incidence of clinical features in adults with internal ventriculoperitoneal (VP) shunt infections,
* To determine the validity of laboratory parameters in adults with internal ventriculoperitoneal shunt infections and
* To evaluate the relationship between the timing of shunt re-implantation with the rates of relapse and secondary infection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Information from medical records of patients seen by the PI will be collected and analyzed to describe the incidence of clinical features in adults with internal ventriculoperitoneal shunt infections, to determine the validity of laboratory parameters in adults with internal ventriculoperitoneal shunt infections and to evaluate the relationship between the timing of shunt re-implantation with the rates of relapse and secondary infection.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventriculoperitoneal Shunt Infection

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

shunt internal ventriculoperitoneal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults (age \>= 18 yrs) with VP shunts (ventriculoatrial \[VA\], and other cerebrospinal fluid \[CSF\] catheters will not be included).
* Cases will include patients with a diagnosis of VP shunt infection.
* Controls will be patients with a clinical suspicion of shunt infections with negative CSF cultures.

Exclusion Criteria

* Patients with meningitis from community acquired organisms (e.g. Streptococcus pneumoniae, Neisseria meningitidis, Listeria monocytogenes and Haemophilus Influenzae).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Pittsburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Adarsh Bhimraj, MD

Role: PRINCIPAL_INVESTIGATOR

University of Pittsburgh Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRO07080212

Identifier Type: -

Identifier Source: org_study_id